Literature DB >> 191278

Effect of prostaglandin E1 on rat gastric motility and cyclic nucleotide content.

N L Shearin, W L Pancoe.   

Abstract

Administration of exogenous prostaglandin E1 resulted in an increase in contractility of rat fundic muscle measured in vivo; a significant decrease in fundic tissue levels of cyclic- adenosine monophosphate and a significant increase in cyclic-guanosine monophosphate.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 191278     DOI： 10.1007/bf01924448

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  7 in total

1.  Cyclic GMP: Cellular Regulatory Agent?

Authors:  G B Kolata
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

2.  Novel telemetric system for extraluminal measurement of gastrointestinal motility.

Authors:  N L Shearin; C J Pfeiffer; S Kilam
Journal:  J Appl Physiol       Date:  1976-09       Impact factor: 3.531

3.  Radioimmunoassay for cyclic nucleotides. 3. Effect of ischemia, changes during development and regional distribution of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mouse brain.

Authors:  A L Steiner; J A Ferrendelli; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

Review 4.  The role of cyclic AMP in hepatic and gastrointestinal function.

Authors:  R A Levine
Journal:  Gastroenterology       Date:  1970-08       Impact factor: 22.682

Review 5.  Prostaglandins and the gastrointestinal tract.

Authors:  A Bennett; B Fleshler
Journal:  Gastroenterology       Date:  1970-11       Impact factor: 22.682

6.  Motor responses of the human alimentary tract to near-maximal infusions of pentagastrin.

Authors:  J J Misiewicz; D J Holdstock; S L Waller
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

7.  Effects of prostaglandins F2alpha and E1 on the longitudinal and circular smooth muscle of the guinea pig caecum in relation to the concentration of extracellular calcium.

Authors:  O Kadlec; R Radomirov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.